ask="13.65"
ask_size="300"
average_daily_volume="1973210"
bid="13.58"
bid_size="1900"
book_value="-0.09"
change="+0.86"
change_from_200_day_moving_average="3.75"
change_from_50_day_moving_average="2.80"
change_from_52_week_high="-1.20"
change_From_52_week_low="7.28"
change_in_percent="+6.43%"
close="14.24"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.74"
ex_dividend_date="N/A"
float_shares="94960000"
high="14.36"
high_52_weeks="15.44"
last_trade_date="1/9/2017"
last_trade_price="14.24"
last_trade_size="181824"
last_trade_time="4:00pm"
low="13.24"
low_52_weeks="6.96"
market_capitalization="1.82B"
moving_average_200_day="10.49"
moving_average_50_day="11.44"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.84"
open="13.38"
pe_ratio="N/A"
peg_ratio="-0.31"
percent_change_from_200_day_moving_average="+35.70%"
percent_change_from_50_day_moving_average="+24.53%"
percent_change_from_52_week_high="-7.77%"
percent_change_from_52_week_low="+104.60%"
previous_close="13.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="10.72"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="15.05"
stock_exchange="NMS"
symbol="HALO"
volume="4170722"
weeks_range_52="6.96 - 15.44"
